These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 18853040)
1. Purinergic signalling: past, present and future. Burnstock G Braz J Med Biol Res; 2009 Jan; 42(1):3-8. PubMed ID: 18853040 [TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling: Its unpopular beginning, its acceptance and its exciting future. Burnstock G Bioessays; 2012 Mar; 34(3):218-25. PubMed ID: 22237698 [TBL] [Abstract][Full Text] [Related]
6. Historical review: ATP as a neurotransmitter. Burnstock G Trends Pharmacol Sci; 2006 Mar; 27(3):166-76. PubMed ID: 16487603 [TBL] [Abstract][Full Text] [Related]
7. Purinergic signalling: from normal behaviour to pathological brain function. Burnstock G; Krügel U; Abbracchio MP; Illes P Prog Neurobiol; 2011 Oct; 95(2):229-74. PubMed ID: 21907261 [TBL] [Abstract][Full Text] [Related]
8. Introduction to Purinergic Signalling in the Brain. Burnstock G Adv Exp Med Biol; 2020; 1202():1-12. PubMed ID: 32034706 [TBL] [Abstract][Full Text] [Related]
9. Introductory overview of purinergic signalling. Burnstock G Front Biosci (Elite Ed); 2011 Jun; 3(3):896-900. PubMed ID: 21622101 [TBL] [Abstract][Full Text] [Related]
10. Introduction to purinergic signalling in the brain. Burnstock G Adv Exp Med Biol; 2013; 986():1-12. PubMed ID: 22879061 [TBL] [Abstract][Full Text] [Related]
11. Physiology and pathophysiology of purinergic neurotransmission. Burnstock G Physiol Rev; 2007 Apr; 87(2):659-797. PubMed ID: 17429044 [TBL] [Abstract][Full Text] [Related]
12. Overview. Purinergic mechanisms. Burnstock G Ann N Y Acad Sci; 1990; 603():1-17; discussion 18. PubMed ID: 1981306 [TBL] [Abstract][Full Text] [Related]
15. Physiopathological roles of P2X receptors in the central nervous system. Burnstock G Curr Med Chem; 2015; 22(7):819-44. PubMed ID: 25005189 [TBL] [Abstract][Full Text] [Related]
16. The journey to establish purinergic signalling in the gut. Burnstock G Neurogastroenterol Motil; 2008 May; 20 Suppl 1():8-19. PubMed ID: 18402638 [TBL] [Abstract][Full Text] [Related]
17. Potential therapeutic targets in the rapidly expanding field of purinergic signalling. Burnstock G Clin Med (Lond); 2002; 2(1):45-53. PubMed ID: 11871639 [TBL] [Abstract][Full Text] [Related]
18. ATP- and adenosine-mediated signaling in the central nervous system: adenosine receptor activation by ATP through rapid and localized generation of adenosine by ecto-nucleotidases. Matsuoka I; Ohkubo S J Pharmacol Sci; 2004 Feb; 94(2):95-9. PubMed ID: 14978343 [TBL] [Abstract][Full Text] [Related]
19. Purinergic Signalling and Neurological Diseases: An Update. Burnstock G CNS Neurol Disord Drug Targets; 2017; 16(3):257-265. PubMed ID: 27658510 [TBL] [Abstract][Full Text] [Related]
20. Unresolved issues and controversies in purinergic signalling. Burnstock G J Physiol; 2008 Jul; 586(14):3307-12. PubMed ID: 18499722 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]